Weaver v. Secretary of Health and Human Services ( 2020 )


Menu:
  •     In the United States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    No. 18-1742V
    (not to be published)
    JACQUELINE WEAVER,
    Chief Special Master Corcoran
    Petitioner,
    v.                                                          Filed: November 17, 2020
    SECRETARY OF HEALTH AND                                     Special Processing Unit                 (SPU);
    HUMAN SERVICES,                                             Attorney’s Fees and Costs
    Respondent.
    Jeffrey S. Pop, Jeffrey S. Pop & Associates, Beverly Hills, CA, for Petitioner.
    Lisa Ann Watts, U.S. Department of Justice, Washington, DC, for Respondent.
    DECISION ON ATTORNEY’S FEES AND COSTS 1
    On November 8, 2018, Jacqueline Weaver (“Petitioner”), filed a petition for
    compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.
    §300aa-10, et seq. 2 (the “Vaccine Act”). Petitioner alleges that she suffered a shoulder
    injury related to vaccine administration which meets the Table definition for SIRVA after
    receiving the influenza vaccine on October 2, 2017. (Petition at 1). On August 7, 2020, a
    decision was issued awarding compensation to Petitioner based on the parties’
    stipulation. (ECF No. 32).
    1  Because this unpublished Decision contains a reasoned explanation for the action in this case, I am
    required to post it on the United States Court of Federal Claims' website in accordance with the E-
    Government Act of 2002. 
    44 U.S.C. § 3501
     note (2012) (Federal Management and Promotion of Electronic
    Government Services). This means the Decision will be available to anyone with access to the
    internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact
    medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.
    If, upon review, I agree that the identified material fits within this definition, I will redact such material from
    public access.
    2
    National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 
    100 Stat. 3755
    . Hereinafter, for ease
    of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
    300aa (2012).
    Petitioner has now filed a motion for attorney’s fees and costs, dated October 29,
    2020, (ECF No. 37), requesting a total award of $15,007.55 (representing $14,474.80 in
    fees and $532.75 in costs). In accordance with General Order No. 9, Petitioner filed a
    signed statement indicating that she incurred no out-of-pocket expenses (ECF No. 37-4).
    Respondent reacted to the motion on October 30, 2020, indicating that he is satisfied that
    the statutory requirements for an award of attorney’s fees and costs are met in this case
    and defers to my discretion to determine the amount to be awarded (ECF No. 38).
    Petitioner did not file a reply thereafter.
    I have reviewed the billing records submitted with Petitioner’s request. In my
    experience, the request appears reasonable, and I find no cause to reduce the requested
    hours or rates.
    The Vaccine Act permits an award of reasonable attorney’s fees and costs. Section
    15(e). Accordingly, I hereby GRANT Petitioner’s Motion for attorney’s fees and costs. I
    award a total of $15,007.55 (representing $14,474.80 in fees and $532.75 in costs) as a
    lump sum in the form of a check jointly payable to Petitioner and Petitioner’s counsel. In
    the absence of a timely-filed motion for review (see Appendix B to the Rules of the Court),
    the Clerk shall enter judgment in accordance with this decision. 3
    IT IS SO ORDERED.
    s/Brian H. Corcoran
    Brian H. Corcoran
    Chief Special Master
    3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice
    renouncing their right to seek review.
    2
    

Document Info

Docket Number: 18-1742

Judges: Brian H. Corcoran

Filed Date: 12/17/2020

Precedential Status: Non-Precedential

Modified Date: 12/17/2020